Similar Articles
1661 Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence
1662 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma
1663 Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients
1664 Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study
1665 Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
1666 Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: Dysregulation and implications for early detection, diagnosis and therapy
1667 Liver function impairment in liver transplantation and after extended hepatectomy
1668 “Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China
1669 MDCT imaging following nephrectomy for renal cell carcinoma: Protocol optimization and patterns of tumor recurrence
1670 Matching donor to recipient in liver transplantation: Relevance in clinical practice
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA